Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma

Cancer ◽  
2007 ◽  
Vol 109 (8) ◽  
pp. 1646-1653 ◽  
Author(s):  
Nita L. Seibel ◽  
Mark Krailo ◽  
Zhengjia Chen ◽  
John Healey ◽  
Philip P. Breitfeld ◽  
...  
BMJ Open ◽  
2019 ◽  
Vol 9 (7) ◽  
pp. e024921 ◽  
Author(s):  
Negar Pourbordbari ◽  
Allan Riis ◽  
Martin Bach Jensen ◽  
Jens Lykkegaard Olesen ◽  
Michael Skovdal Rathleff

ObjectivesTo identify baseline patient characteristics that are (1) associated with a poor outcome on follow-up regardless of which treatment was provided (prognosis) or (2) associated with a successful outcome to a specific treatment (treatment effect modifiers).DesignSystematic literature review according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines.Data sourcesMedline, Embase, Cinahl, Web of Science, Cochrane, SportDiscus, OT Seeker and PsychInfo were searched for prospective cohort studies up to February 2019 without limitation in publication date.Eligibility criteriaProspective cohort studies reporting either prognostic factors or treatment effect modifiers on persistent musculoskeletal pain in 0-year-old to 19-year-old children and adolescents. Pain caused by tumours, fractures, infections, systemic and neurological conditions were excluded.Outcome measuresOur primary outcome was musculoskeletal pain at follow-up and identification of any baseline characteristics that were associated with this outcome (prognostic factors). No secondary outcomes were declared.MethodTwo reviewers independently screened abstracts and titles. We included prospective cohort studies investigating the prognosis or treatment effect modifiers of 0-year-old to 19-year-old children and adolescents with self-reported musculoskeletal pain. Risk of bias assessment was conducted with the Quality in Prognostic Studies tool.ResultsTwenty-six studies yielding a total of 111 unique prognostic factors were included. Female sex and psychological symptoms were the most frequent investigated prognostic factors. Increasing age, generalised pain, longer pain duration and smoking were other identified prognostic factors. No treatment effect modifiers were identified.ConclusionSeveral prognostic factors are associated with a poor prognosis in children and adolescents with musculoskeletal pain. These prognostic factors may help guide clinical practice and shared decision-making. None of the included studies was conducted within a general practice setting which highlights an area in need of research.PROSPERO registration numberCRD42016041378.


2012 ◽  
Vol 15 (1_suppl) ◽  
pp. 255-266 ◽  
Author(s):  
Justin M. M. Cates ◽  
Cheryl M. Coffin

Extraskeletal cartilaginous, osseous, and chordoid tumors are extraordinarily rare in children and adolescents. These lesions are diagnostically challenging due to their rarity and their overlap with metastatic osteosarcoma, reactive or metabolic calcifying and bone-forming masses, various pseudosarcomatous proliferations such as myositis ossificans, and other rare genetic or metabolic disorders. This article reviews the clinicopathologic features and differential diagnosis of extraskeletal cartilaginous, osseous, and chordoid neoplasms in the first two decades of life and highlights the use of diagnostic adjuncts.


Author(s):  
Devi Dayal ◽  
Arti Yadav

Recent reports suggest that the clinical course of coronavirus disease 2019 (COVID-19) in previously healthy children is usually milder as compared to adults. However, children with comorbid conditions such as diabetes are at increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as well as morbidity and mortality due to COVID-19. Experience in adults with diabetes shows that they are prone to faster metabolic decompensation, develop diabetes-related complications, and have a poor prognosis when hospitalized with COVID-19. Data on children are limited. The aim of this mini-review is to discuss the possible risks to children and adolescents with diabetes during the current pandemic and the special considerations in management in those affected with COVID-19. The challenges for children who develop new-onset type 1 diabetes during the COVID-19 lockdown, especially in accessing healthcare, are also discussed.


2015 ◽  
Vol 50 (1) ◽  
pp. 157-160 ◽  
Author(s):  
Austen D. Slade ◽  
Carla L. Warneke ◽  
Dennis P. Hughes ◽  
Pamela A. Lally ◽  
Kevin P. Lally ◽  
...  

2009 ◽  
Vol 45 (11) ◽  
pp. 2007-2014 ◽  
Author(s):  
Pamela S. Hinds ◽  
Jami S. Gattuso ◽  
Catherine A. Billups ◽  
Nancy K. West ◽  
Jianrong Wu ◽  
...  

2021 ◽  
Vol 41 ◽  
pp. 101155
Author(s):  
Qianling Shi ◽  
Zijun Wang ◽  
Jiao Liu ◽  
Xingmei Wang ◽  
Qi Zhou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document